跳至主要内容
临床试验/IRCT20201001048897N1
IRCT20201001048897N1已完成2 期

Therapeutic Efficacy of Urtica dioica and Evening Primrose in Patients with Rheumatoid Arthritis: A Randomized Double-Blind, Placebo-Controlled Clinical Trial

Metabolic Diseases Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.0 个研究点目标入组 90 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • RA was diagnosed according to the revised 2010 American College of Rheumatology (ACR) criteria

排除标准

  • Patients with cardiovascular disease
  • Patients with respiratory diseases
  • Patients with renal disease
  • Patients with liver disease
  • Patients under sex hormone therapy
  • Use supplements before the intervention
  • Changing the treatment of RA patients
  • Allergy to nettle
  • Patients with other inflammatory diseases

研究者

发起方
Metabolic Diseases Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.

相似试验